Zi-Jian Wang1,2,3,4, Aoife Hanet2,3,5, Daniel Weishäupl2,3,4, Inês M Martins2,3, Anna S Sowa2,3,4, Olaf Riess2,3, Thorsten Schmidt2,3. 1. Genetic Engineering Laboratory, College of Biological and Environmental Engineering, Xi'an University, Xi'an, Shaanxi, China. 2. Institute of Medical Genetics & Applied Genomics, University of Tuebingen, Tuebingen, Germany. 3. Center for Rare Diseases (ZSE), University Hospital Tuebingen, Tuebingen, Germany. 4. Graduate Training Centre of Neuroscience, University of Tuebingen, Tuebingen, Germany. 5. Department of Biochemistry, Max Planck Institute for Developmental Biology, Tuebingen, Germany.
Abstract
BACKGROUND & AIMS: Spinocerebellar ataxia type 3 (SCA3), also known as Machado-Joseph disease (MJD), is an autosomal dominantly inherited neurodegenerative disorder and the most common form of SCA worldwide. It is caused by the expansion of a polyglutamine (polyQ) tract in the ataxin-3 protein. Nuclear localization of the affected protein is a key event in the pathology of SCA3 via affecting nuclear organization, transcriptional dysfunction, and seeding aggregations, finally causing neurodegeneration and cell death. So far, there is no effective therapy to prevent or slow the progression of SCA3. METHODS: In this study, we explored the effect of divalproex sodium as an HDACi in SCA3 cell models and explored how divalproex sodium interferes with pathogenetic processes causing SCA3. RESULTS: We found that divalproex sodium rescues the hypoacetylation levels of histone H3 and attenuates cellular cytotoxicity induced by expanded ataxin-3 partly via preventing nuclear transport of ataxin-3 (particularly heat shock-dependent). CONCLUSION: Our study provides novel insights into the mechanisms of action of divalproex sodium as a possible treatment for SCA3, beyond the known regulation of transcription.
BACKGROUND & AIMS:Spinocerebellar ataxia type 3 (SCA3), also known as Machado-Joseph disease (MJD), is an autosomal dominantly inherited neurodegenerative disorder and the most common form of SCA worldwide. It is caused by the expansion of a polyglutamine (polyQ) tract in the ataxin-3 protein. Nuclear localization of the affected protein is a key event in the pathology of SCA3 via affecting nuclear organization, transcriptional dysfunction, and seeding aggregations, finally causing neurodegeneration and cell death. So far, there is no effective therapy to prevent or slow the progression of SCA3. METHODS: In this study, we explored the effect of divalproex sodium as an HDACi in SCA3 cell models and explored how divalproex sodium interferes with pathogenetic processes causing SCA3. RESULTS: We found that divalproex sodium rescues the hypoacetylation levels of histone H3 and attenuates cellular cytotoxicity induced by expanded ataxin-3 partly via preventing nuclear transport of ataxin-3 (particularly heat shock-dependent). CONCLUSION: Our study provides novel insights into the mechanisms of action of divalproex sodium as a possible treatment for SCA3, beyond the known regulation of transcription.
Authors: H L Paulson; M K Perez; Y Trottier; J Q Trojanowski; S H Subramony; S S Das; P Vig; J L Mandel; K H Fischbeck; R N Pittman Journal: Neuron Date: 1997-08 Impact factor: 17.173
Authors: Paul Michel Aloyse Antony; Simone Mäntele; Phillip Mollenkopf; Jana Boy; Ralph H Kehlenbach; Olaf Riess; Thorsten Schmidt Journal: Neurobiol Dis Date: 2009-08-04 Impact factor: 5.996
Authors: Michal Mielcarek; Caroline L Benn; Sophie A Franklin; Donna L Smith; Ben Woodman; Paul A Marks; Gillian P Bates Journal: PLoS One Date: 2011-11-28 Impact factor: 3.240
Authors: Emma Hockly; Victoria M Richon; Benjamin Woodman; Donna L Smith; Xianbo Zhou; Eddie Rosa; Kirupa Sathasivam; Shabnam Ghazi-Noori; Amarbirpal Mahal; Philip A S Lowden; Joan S Steffan; J Lawrence Marsh; Leslie M Thompson; Cathryn M Lewis; Paul A Marks; Gillian P Bates Journal: Proc Natl Acad Sci U S A Date: 2003-02-07 Impact factor: 11.205
Authors: Maxinne Watchon; Luan Luu; Katherine J Robinson; Kristy C Yuan; Alana De Luca; Hannah J Suddull; Madelaine C Tym; Gilles J Guillemin; Nicholas J Cole; Garth A Nicholson; Roger S Chung; Albert Lee; Angela S Laird Journal: Mol Brain Date: 2021-08-20 Impact factor: 4.041